Prolactinoma: a question of rational treatment
The introduction of assays for human prolactin' and the use of drugs such as bromocriptine for treating hyperprolactinaemia2 have had a major impact on the diagnosis and initial management of prolactin-secreting tumours. Many 30 Women with macroadenomas who do not intend to have children may be treated with radiotherapy to inhibit growth of the tumour. Radiotherapy may also reduce serum concentrations of prolactin, 3' and so avoid indefinite and expensive treatment with bromocriptine.
The diagnosis of a microprolactinoma is more difficult. The pituitary fossa is not obviously enlarged, and the differential diagnosis rests between prolactinoma, hypothalamic disease, and "functional" hyperprolactinaemia. ' 3 Subtle abnormalities in the contour of the sella turcica may indicate the presence of a microadenoma,32 but recent evidence suggests that these abnormalities should be interpreted with caution.33 Greater reliance should be placed on the serum concentration of prolactin; when this is over 2000 mU,/l a microprolactinoma is the likely diagnosis, but the possibility can also be entertained at lower concentrations on the basis of an inhibited response to dynamic testing. '6 Release tests may accurately identify a microprolactinoma34 35 -and these are essential before transsphenoidal microsurgery-but we are no nearer understanding the pathophysiology of hyperprolactinaemia in patients with normal responses. Might these patients also harbour microadenomas ? Autonomous secretion by small microprolactinomas may have too small an effect to produce inhibition of the normal lactotrophs via the feedback loop. Nevertheless, whatever the response to dynamic tests, all these patients can be treated with bromocriptine to restore fertility and relieve symptoms. The risk of expansion of a microprolactinoma during pregnancy is small (6%),27 but monthly follow-up throughout pregnancy is still advisable, with testing of the visual fields and assessment of serum concentrations of prolactin. The 
